Position in ZYME
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$5,928,319
+$3,571,154 QoQ
Shares Held
236,754
+164.5% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Derivatives in ZYME
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$1,708,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. ZYME ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ZYME
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,928,319 | 236,754 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,357,165 | 89,524 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,286,584 | 75,327 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $1,708,000 | 100,000 | Put | Defined | 2026-02-03 | |
| 2025-06-30 | $1,134,243 | 90,378 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $739,979 | 62,131 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $464,087 | 31,700 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $875,111 | 69,730 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $783,055 | 92,016 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $560,799 | 53,308 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $983,340 | 94,643 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $568,697 | 89,700 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $663,153 | 76,754 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $979,528 | 108,355 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $220,920 | 28,107 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||